Meeting To Evaluate Vitamin D’s Role In MS

On Saturday, Oct. 17, leading multiple sclerosis (MS) researchers from around the country will meet at the Hyatt Regency, Boston, to evaluate the feasibility of conducting what would be the largest clinical study ever undertaken to explore the role that vitamin D may play in MS. The meeting will be led by Dr. Benjamin Greenberg, deputy director of the MS program and director of the new Transverse Myelitis and Neuromyelitis Optica Program at University of Texas Southwestern Medical Center, and is being organized under the auspices of the nonprofit organization Accelerated Cure Project for Multiple Sclerosis.

The purpose of this meeting is to discuss the feasibility of designing a large-scale study around vitamin D supplementation to evaluate its potential effects early in the course of the disease. This study would also result in the banking of thousands of additional blood samples into the Accelerated Cure Project’s MS sample and data repository for future use in understanding the causes and disease mechanisms of MS.

Source:

AcceleratedCure.org: Multiple Sclerosis Researchers To Meet In Boston To Design Largest-Ever Vitamin D Study

Related Content:

Study: High Vitamin D Dose May Reduce MS Relapses

Vitamin D May Lower Risk Of Multiple Sclerosis